The Market for Next-Generation-Sequencing Neonatal Testing (NGS-NIPT) in China
Next Generation NIPT Sequencing in China estimates the revenues for non-invasive prenatal testing in this emerging market, and generally analyzes the role of next generation sequencing (NGS) in the country. Estimates in this report include revenues for non-invasive prenatal testing using sequencing in China, projections to 2020, market share. Institutions performing NGS and key equipment manufacturers and service providers are discussed.
This report was created as a cooperative project between Kalorama Information and The Freedonia Group, with staff from Freedonia’s Beijing office completing primary and secondary research.
Search inside this report
Departmental Site License (one location, 10 users)